462 related articles for article (PubMed ID: 28257596)
1. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
[TBL] [Abstract][Full Text] [Related]
2. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.
Enocsson H; Sjöwall C; Kastbom A; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
Arthritis Rheumatol; 2014 Jun; 66(6):1568-73. PubMed ID: 24574329
[TBL] [Abstract][Full Text] [Related]
3. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
Sahin S; Adrovic A; Barut K; Durmus S; Gelisgen R; Uzun H; Kasapcopur O
Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068
[TBL] [Abstract][Full Text] [Related]
4. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
Cieślik P; Hrycek A
Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus.
Shimada Y; Asanuma YF; Yokota K; Yoshida Y; Kajiyama H; Sato K; Akiyama Y; Mimura T
Mod Rheumatol; 2014 Jan; 24(1):78-85. PubMed ID: 24261762
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
Enocsson H; Wetterö J; Eloranta ML; Gullstrand B; Svanberg C; Larsson M; Bengtsson AA; Rönnblom L; Sjöwall C
Front Immunol; 2021; 12():688753. PubMed ID: 34276678
[TBL] [Abstract][Full Text] [Related]
7. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
8. Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis.
Wu Q; Guan SY; Dan YL; Zhao CN; Mao YM; Liu LN; Li XM; Wang DG; Pan HF
Biomark Med; 2019 Nov; 13(16):1417-1427. PubMed ID: 31599644
[No Abstract] [Full Text] [Related]
9. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
Yuan M; Tan Y; Pang Y; Li YZ; Song Y; Yu F; Zhao MH
Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
[TBL] [Abstract][Full Text] [Related]
10. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and pentraxin 3 (PTX3) as markers of infection in febrile patients with systemic lupus erythematosus.
Kim J; Koh JK; Lee EY; Park JA; Kim HA; Lee EB; Garlanda C; Cotena A; Song YW
Clin Exp Rheumatol; 2009; 27(5):773-8. PubMed ID: 19917159
[TBL] [Abstract][Full Text] [Related]
12. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.
Fazzini F; Peri G; Doni A; Dell'Antonio G; Dal Cin E; Bozzolo E; D'Auria F; Praderio L; Ciboddo G; Sabbadini MG; Manfredi AA; Mantovani A; Querini PR
Arthritis Rheum; 2001 Dec; 44(12):2841-50. PubMed ID: 11762945
[TBL] [Abstract][Full Text] [Related]
13. PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis.
Bassi N; Del Prete D; Ghirardello A; Gatto M; Ceol M; Zen M; Bettio S; Mantovani A; Iaccarino L; Punzi L; Doria A
Clin Rev Allergy Immunol; 2015 Oct; 49(2):217-26. PubMed ID: 25805362
[TBL] [Abstract][Full Text] [Related]
14. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
[TBL] [Abstract][Full Text] [Related]
15. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
Lin LH; Ling P; Liu MF
J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
[TBL] [Abstract][Full Text] [Related]
16. Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis.
Gatto M; Wiedemann A; Nomovi N; Reiter K; Schrezenmeier E; Rose T; Szelinski F; Lino AC; Valentino S; Ghirardello A; Dörner T; Doria A
Front Immunol; 2019; 10():29. PubMed ID: 30740098
[No Abstract] [Full Text] [Related]
17. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus.
Bassi N; Ghirardello A; Blank M; Zampieri S; Sarzi-Puttini P; Mantovani A; Shoenfeld Y; Doria A
Ann Rheum Dis; 2010 Sep; 69(9):1704-10. PubMed ID: 20439287
[TBL] [Abstract][Full Text] [Related]
18. Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration.
Juel HB; Faber C; Munthe-Fog L; Bastrup-Birk S; Reese-Petersen AL; Falk MK; Singh A; Sørensen TL; Garred P; Nissen MH
PLoS One; 2015; 10(7):e0132800. PubMed ID: 26176960
[TBL] [Abstract][Full Text] [Related]
19. Association of Polymorphisms in C-Reactive Protein (CRP) Promoter -821 A>G, -390 C>A/T, and Plasma Interferon-α (IFN-α) with Plasma CRP Level in Javanese Systemic Lupus Erythematosus (SLE) Patients.
Awalia A; Notopuro H; Soeroso J
Acta Med Indones; 2021 Jul; 53(3):261-267. PubMed ID: 34611064
[TBL] [Abstract][Full Text] [Related]
20. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
